Cambridge-based organ-on-chip technology company CN Bio has introduced a new in vitro assay kit designed to assess human oral drug bioavailability. The PhysioMimix Bioavailability assay kit: Human 18 enables pharmaceutical researchers to generate predictive human data earlier in the drug development pipeline, reducing reliance on animal studies.
Cambridge-based Enhanc3D Genomics has unveiled an integrated suite of multi-omics solutions designed to enhance drug discovery processes. The platform, which leverages proprietary Promoter Capture Hi-C technology, enables high-resolution mapping of genomewide regulatory interactions to support more targeted therapeutic development approaches.
Revvity Inc has announced FDA 510(k) clearance for EUROIMMUN’s automated chemilumin-escence immunoassay (ChLIA) for direct quantitative measurement of free testosterone. The assay, which runs on the company’s iSYS and i10 platforms, represents the first FDA-cleared automated direct measurement method for free testosterone in human serum or plasma.
Laboratory software provider Sapio Sciences has announced significant updates to its informatics platform, enhancing functionality across chemistry, immunogenicity, GMP workflows and molecular biology. Release 24.12 introduces automated validation tools and refined chemistry representation capabilities, aimed at improving laboratory efficiency and data management.
A new sequential DNA/RNA isolation kit has been launched by Thermo Fisher Scientific, designed to streamline genomic analysis workflows in haematological cancer research. The MagMAX Sequential DNA/RNA kit enables concurrent extraction of DNA and RNA from a single sample, potentially accelerating research into blood-based malignancies.
TRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.
Bio-Rad Laboratories has enhanced its downstream bioprocessing capabilities with larger-diameter prepacked chromatography columns. The expansion builds upon their existing Foresight Pro range, offering increased scalability options for the purification of biotherapeutics including monoclonal antibodies, recombinant proteins, and vaccines.
International medical technology company Mindray has introduced new platelet counting technology to European markets, incorporating artificial intelligence and multiple detection methods to enhance accuracy in clinical haematology laboratories. The CAL 8000 Cellular Analysis Line aims to reduce pseudothrombocytopenia and pseudothrombocytosis errors in diagnostic testing.
A programmable five-position stirring hot plate offering precise temperature control and multiple stirring positions has been launched by Torrey Pines Scientific. The EchoTherm Model HS65 aims to enhance laboratory workflow efficiency in chemical, pharmaceutical, environmental and biochemical applications where reproducible sample preparation is essential.
Cambridge-based Panakeia has announced PANProfiler Colon, an artificial intelligence-driven software tool that determines micro-satellite instability (MSI) and mismatch repair deficiency (dMMR) status from H&E-stained tissue samples within minutes. The technology aims to accelerate molecular profiling for precision medicine in colorectal cancer treatment.
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.